Featured Publications
Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study
Savinkina A, Bilinski A, Fitzpatrick M, Paltiel AD, Rizvi Z, Salomon J, Thornhill T, Gonsalves G. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study. BMJ Open 2022, 12: e061752. PMID: 36100306, PMCID: PMC9471205, DOI: 10.1136/bmjopen-2022-061752.Peer-Reviewed Original ResearchMeSH KeywordsCost-Benefit AnalysisCOVID-19COVID-19 VaccinesDeveloping CountriesHumansMRNA VaccinesRNA, MessengerRNA, ViralSARS-CoV-2VaccinationVaccines, SyntheticConceptsLow-income countriesIncome countriesDeath avertedHigh-income nationsStatistical lifeAvertable deathsIncome nationsCOVID-19 deathsReasonable investmentHigh costKey inputCountriesParameter estimatesAvertedCostSensitivity analysisUniversal vaccinationGlobal vaccinationMRNA COVID-19 vaccinationNationsInvestmentPrimary vaccine seriesLow vaccine effectivenessCOVID-19 vaccinationPublic data
2022
End COVID-19 in low- and middle-income countries
Mobarak AM, Miguel E, Abaluck J, Ahuja A, Alsan M, Banerjee A, Breza E, Chandrasekhar AG, Duflo E, Dzansi J, Garrett D, Goldsmith-Pinkham P, Gonsalves GS, Hossain MM, Jakubowski A, Kang G, Kharel A, Kremer M, Meriggi N, Nekesa C, Olken BA, Omer SB, Qadri F, Rees H, Salako B, Voors M, Warren S, Więcek W. End COVID-19 in low- and middle-income countries. Science 2022, 375: 1105-1110. PMID: 35271319, DOI: 10.1126/science.abo4089.Commentaries, Editorials and Letters
2011
No Need for Apologies
El-Sadr WM, Gonsalves G, Mugyenyi P. No Need for Apologies. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2011, 57: s68-s71. PMID: 21857299, DOI: 10.1097/qai.0b013e31821db9d0.Peer-Reviewed Original Research
2010
AIDS Funds: Undervalued
Nattrass N, Gonsalves G. AIDS Funds: Undervalued. Science 2010, 330: 174.2-175. PMID: 20929755, DOI: 10.1126/science.330.6001.174-b.Peer-Reviewed Original Research
2006
Scaling up antiretroviral treatment in resource-poor settings
Batz HG, Guillerm M, Gonsalves G. Scaling up antiretroviral treatment in resource-poor settings. The Lancet 2006, 368: 445. PMID: 16890819, DOI: 10.1016/s0140-6736(06)69139-3.Peer-Reviewed Original Research
2005
Promote HIV Chemoprophylaxis Research, Don't Prevent It
Grant RM, Buchbinder S, Cates W, Clarke E, Coates T, Cohen MS, Delaney M, Flores G, Goicochea P, Gonsalves G, Harrington M, Lama JR, MacQueen KM, Moore JP, Peterson L, Sanchez J, Thompson M, Wainberg MA. Promote HIV Chemoprophylaxis Research, Don't Prevent It. Science 2005, 309: 2170-2171. PMID: 16195446, DOI: 10.1126/science.1116204.Peer-Reviewed Original Research
2002
HIV/AIDS prevention and treatment
Gonsalves G. HIV/AIDS prevention and treatment. The Lancet 2002, 360: 87. PMID: 12114065, DOI: 10.1016/s0140-6736(02)09344-3.Peer-Reviewed Original ResearchNext steps on ART
Gonsalves G. Next steps on ART. Nature Medicine 2002, 8: 644-644. PMID: 12091884, DOI: 10.1038/nm0702-644.Peer-Reviewed Original Research